Affordability Check
How to afford Entyvio
Generic name: vedolizumab
Pick how you're covered. We'll show you the cheapest legitimate way to get Entyvio — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About Entyvio and its cost
What is this medication? Entyvio is a prescription biologic medication used to treat adults with moderate to severe ulcerative colitis and Crohn's disease. These conditions are types of inflammatory bowel disease that cause chronic swelling and irritation in the digestive tract. Doctors typically prescribe this medication when other treatments, such as certain steroids or immunosuppressants, have not worked well enough or cannot be tolerated. It is most commonly administered as an intravenous infusion in a clinical setting or, in some cases, as a subcutaneous injection.
The medication works by specifically targeting the immune system response within the gut to reduce inflammation. It is classified as an integrin receptor antagonist, which means it blocks specific white blood cells from entering the gastrointestinal tract. By preventing these inflammatory cells from moving into the gut tissue, Entyvio helps to decrease the symptoms of the disease and can help patients achieve and maintain remission. Because it focuses on the digestive system, it is designed to treat the condition without suppressing the entire body's immune system.
Entyvio is made by Takeda. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford Entyvio?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for Entyvio?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Takeda has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover Entyvio?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Ulcerative Colitis and Crohn’s Disease?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about Entyvio
Full Entyvio drug page
FDA label, prior authorization rules, full indications list
More options for Ulcerative Colitis and Crohn’s Disease
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3